A psychometric evaluation of the diabetes symptom checklist-revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes

Diabetes, Metabolic Syndrome and Obesity

Volumn 3, Issue , 2010, Pages 27-30

  Naegeli, April N ^a   Stump, Timothy E ^b   Hayes, Risa P ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

Diabetes symptom checklist revised; DSC R; Psychometric validation; Type 1 diabetes; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; FATIGUE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY; WELLBEING;

EID: 77953454467     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/dmsott.s9465     Document Type: Article

References (19)

1. American Diabetes Association. Available from: http://www.diabetes.org/ Accessed on January 10, 2010
2. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabet Med. 1994;11:253-261
3. Arbuckle RA, Humphrey L, Vardeva K, et al. Psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) - A measure of symptom distress. Value Health. 2009;12(8):1168-1175
4. Gulliford MC, Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago. J Clin Epidemiol. 1999;52(8):773-780
5. Adriaanse MC, Dekker JM, Spijkerman AMW, et al. Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients: the Hoorn Screening Study. Diabet Med. 2004;21:1075-1081
6. Adriaanse MC, Dekker JM, Spijkerman AMW, et al. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening study. Qual Life Res. 2005;14:1501-1509
7. de Sonnaville JJJ, Snoek FJ, Colly LP, Deville W, Wijkel D, Heine RJ. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care. 1998;21(6):919-924
8. Van der Does FEE, de Neeling JND, Snoek FJ. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care. 1996;19:204-210
9. Van der Does FEE, de Neeling JND, Snoek F. Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes: effects on well-being at 1 year. Diabetes Care. 1998;21(12):2085-2093
10. Vinik AI, Dailey G, Zhang Q. Insulin glargine (GLAR) improves health related quality of life (HRQOL) in patients with Type 2 Diabetes (T2DM) inadequately controlled on sulfonylurea plus metformin (SU+MET) (Abstract). Diabetes. 2005;54(Suppl 1):A142
11. Gross JL, Nakano M, Colon-Vega G, et al. Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with Type 2 diabetes: a randomized noninferiority trial. Diabetes Technol Ther. 2009;11(2):S27-S34
12. Comulada AL, Renard E, Nakano M, et al. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial. Diabetes Technol Ther. 2009;11(2):S17-S25
13. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6(1):1-55
14. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1988
15. Bradley C. The diabetes treatment satisfaction questionnaire. In: Bradley C, editor. Handbook of Psychology and Diabetes: A guide to psychological measurement in diabetes research and practice. Chur, Switzerland: Harwood Academic Publishers; 1994, p. 111-132
16. Bradley C. The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability. Diabetes Care. 2000;23:875
17. Peyrot M, Rubin RR. How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference. Diabetes Care. 2009;32(8):1411-1417
18. Hayes RP, Bowman L, Monahan PO, Marrero DG, McHorney CA. Understanding diabetes medications from the perspective of patients with Type 2 diabetes: prerequisite to medication concordance. Diabetes Educ. 2006;32(3):404-414
19. Hayes RP, Muchmore DB. Patients with Type 2 diabetes on oral antidiabetic therapy report similar treatment satisfaction, well-being, and symptom burden regardless of degree of glycemic control [Abstract]. Diabetes. 2008:A1385.